# Unloading in Heart Failure Cardiogenic Shock

Study · id `cardio:ct-nct05064202` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05064202](<https://clinicaltrials.gov/study/NCT05064202>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05064202

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 456 participants.

## Technical summary

Registry record NCT05064202. Randomized; no masking; primary purpose treatment. Start 2023-10-01 (anticipated); primary completion 2027-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 456 participants (planned count; ClinicalTrials.gov record NCT05064202, source copy `cardio:ctgov-nct05064202-2023-08-01`, retrieved 2026-10-31)
- Planned start: 2023-10-01 (anticipated) (ClinicalTrials.gov record NCT05064202, source copy `cardio:ctgov-nct05064202-2023-08-01`, retrieved 2026-10-31)
- Primary completion: 2027-10-01 (anticipated) (ClinicalTrials.gov record NCT05064202, source copy `cardio:ctgov-nct05064202-2023-08-01`, retrieved 2026-10-31)
- Completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT05064202, source copy `cardio:ctgov-nct05064202-2023-08-01`, retrieved 2026-10-31)
- Countries: Netherlands (ClinicalTrials.gov record NCT05064202, source copy `cardio:ctgov-nct05064202-2023-08-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05064202-2023-08-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: Unloading in Heart Failure Cardiogenic Shock
- Acronym: UNLOAD HF-CS
- Condition: Cardiogenic Shock
- Intervention (Device): Impella 5.5
- Intervention (Drug): Inotropes
- Lead sponsor: Amsterdam UMC, location VUmc
- Lead sponsor class: OTHER
- Collaborator: Abiomed Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry lists this organization as the lead sponsor: Amsterdam UMC, location VUmc (`cardio:org-amsterdam-umc-location-vumc`)
- Registry lists this organization as a collaborator: Abiomed Inc. (`cardio:org-abiomed-inc`)

## Provenance

Content hash: 49d41bebf096723d26292c4742626d9c31a678835022ba2dded99f6ffb9bddc3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
